Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 15, 2021 at 08:45 am
Share
Jiangxi Synergy Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 137.346 million compared to CNY 96.684 million a year ago. Operating income was CNY 22.069 million compared to CNY 17.878 million a year ago. Net income was CNY 20.137 million compared to CNY 15.790 million a year ago. Basic earnings per share from continuing operations was CNY 0.1566 compared to CNY 0.1964 a year ago.
Jiangxi Synergy Pharmaceutical Co Ltd is a pharmaceutical manufacturing company. The Company is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The Company's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The company's products are sold to domestic and foreign markets, including Europe, North America and Japan.